Ani Pharmaceuticals (ANIP) Other Non Operating Income (2011 - 2026)
Ani Pharmaceuticals (ANIP) reported Other Non Operating Income of -$651000.0 for Q1 2026, down 428.79% on a YoY basis from $198000.0 in Q1 2025, and down 137.44% sequentially from $1.7 million in Q2 2025.
Ani Pharmaceuticals (ANIP) Other Non Operating Income (2011 - 2026) Analysis & Trends
Ani Pharmaceuticals (ANIP) has 16 years of Other Non Operating Income data on file, last reported at -$651000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income fell 428.79% year-over-year to -$651000.0; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 112.45% YoY), and the FY2024 full-year result was -$4.0 million, changed N/A from the prior year.
- Other Non Operating Income eased to -$651000.0 in Q1 2026, from $1.7 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $1.7 million in Q2 2025 to a low of -$7.5 million in Q3 2024.
- A 5-year average of -$545923.1 and a median of -$42000.0 in 2022 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income surged 2076.14% in 2025 and plunged 428.79% in 2026, its largest moves.
- Tracing ANIP's Other Non Operating Income over 5 years: stood at -$42000.0 in 2022, then declined by 26.19% to -$53000.0 in 2023, then slumped by 2500.0% to -$1.4 million in 2024, then jumped by 226.2% to $1.7 million in 2025, then plunged by 137.44% to -$651000.0 in 2026.
- Business Quant data shows ANIP's Other Non Operating Income at -$651000.0 in Q1 2026, $1.7 million in Q2 2025, and $198000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.33 Bn | 143.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -651,000.00 |
| Jun 30, 2025 | 1.74 Mn |
| Mar 31, 2025 | 198,000.00 |
| Dec 31, 2024 | -1.38 Mn |
| Sep 30, 2024 | -7.47 Mn |
| Jun 30, 2024 | -88,000.00 |
| Mar 31, 2024 | -32,000.00 |
| Jun 30, 2023 | -53,000.00 |
| Mar 31, 2023 | -34,000.00 |
| Dec 31, 2022 | -42,000.00 |
| Sep 30, 2022 | 37,000.00 |
| Jun 30, 2022 | 764,000.00 |
| Mar 31, 2022 | -89,000.00 |
| Dec 31, 2021 | -2.69 Mn |
| Sep 30, 2021 | -1.07 Mn |
| Jun 30, 2021 | -67,000.00 |
| Mar 31, 2021 | -515,000.00 |
| Dec 31, 2020 | -159,000.00 |
| Sep 30, 2020 | -229,000.00 |
| Jun 30, 2020 | -116,000.00 |